• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Iron Deficiency Is Associated With More Severe Pulmonary Vascular Disease in Pulmonary Hypertension Caused by Chronic Lung Disease.

作者信息

Tatah Jasmine, Keen Jennifer L, Prisco Sasha Z, Pritzker Marc, Thenappan Thenappan, Prins Kurt W

机构信息

Department of Medicine, Cardiovascular Division, Lillehei Clinical Research Unit, Minneapolis, MN.

Department of Medicine, Pulmonary and Critical Care, Minneapolis, MN.

出版信息

Chest. 2022 Jan;161(1):232-236. doi: 10.1016/j.chest.2021.07.2159. Epub 2021 Aug 2.

DOI:10.1016/j.chest.2021.07.2159
PMID:34352277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8783028/
Abstract
摘要

相似文献

1
Iron Deficiency Is Associated With More Severe Pulmonary Vascular Disease in Pulmonary Hypertension Caused by Chronic Lung Disease.缺铁与慢性肺病所致肺动脉高压中更严重的肺血管疾病相关。
Chest. 2022 Jan;161(1):232-236. doi: 10.1016/j.chest.2021.07.2159. Epub 2021 Aug 2.
2
[Pulmonary hypertension associated with lung pathology - single or multiple causes?].[与肺部病变相关的肺动脉高压——单一病因还是多种病因？]
Pneumonol Alergol Pol. 2013;81(3):187-91.
3
Pulmonary Hypertension due to Lung Diseases and/or Hypoxia: What Do We Actually Know?肺部疾病和/或缺氧所致肺动脉高压：我们究竟了解多少？
Can Respir J. 2017;2017:9598089. doi: 10.1155/2017/9598089. Epub 2017 Aug 28.
4
Soluble Transferrin Receptor-1 in Pulmonary Hypertension Associated with COPD.慢性阻塞性肺疾病相关肺动脉高压中的可溶性转铁蛋白受体-1
Lung. 2025 Jul 14;203(1):79. doi: 10.1007/s00408-025-00833-3.
5
Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.慢性阻塞性肺疾病和间质性肺疾病患者作为肺移植候选者时的肺动脉壁疾病
Respir Res. 2017 May 6;18(1):85. doi: 10.1186/s12931-017-0568-z.
6
Obstructive Sleep Apnea in Patients With Fibrotic Interstitial Lung Disease and COPD.特发性肺纤维化和 COPD 患者的阻塞性睡眠呼吸暂停。
J Clin Sleep Med. 2019 Dec 15;15(12):1807-1815. doi: 10.5664/jcsm.8090. Epub 2019 Oct 26.
7
Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease.夜间低氧血症与间质性肺疾病的不良结局相关。
Respirology. 2019 Oct;24(10):996-1004. doi: 10.1111/resp.13549. Epub 2019 Apr 1.
8
Secondary Pulmonary Hypertension Among Patients Qualified for Lung Transplantation: Single-Center Study.适合肺移植患者的继发性肺动脉高压：单中心研究
Transplant Proc. 2020 Sep;52(7):2101-2109. doi: 10.1016/j.transproceed.2020.02.120. Epub 2020 Apr 24.
9
Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.研究右心超声心动图指标在检测晚期肺病患者肺动脉高压方面的价值。
Int J Cardiovasc Imaging. 2017 Jun;33(6):825-835. doi: 10.1007/s10554-017-1069-3. Epub 2017 Jan 24.
10
Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort.慢性阻塞性肺疾病相关重度肺动脉高压：一项前瞻性法国多中心队列研究。
J Heart Lung Transplant. 2021 Sep;40(9):1009-1018. doi: 10.1016/j.healun.2021.04.021. Epub 2021 May 11.

引用本文的文献

1
Reassessment of the Current Iron Deficiency Definition in Pulmonary Hypertension.肺动脉高压中当前缺铁定义的重新评估
Pulm Circ. 2025 Jul 29;15(3):e70142. doi: 10.1002/pul2.70142. eCollection 2025 Jul.
2
Soluble Transferrin Receptor-1 in Pulmonary Hypertension Associated with COPD.慢性阻塞性肺疾病相关肺动脉高压中的可溶性转铁蛋白受体-1
Lung. 2025 Jul 14;203(1):79. doi: 10.1007/s00408-025-00833-3.
3
Iron Deficiency and All-Cause Hospitalization Risk in a Clinical Cohort of COPD.慢性阻塞性肺疾病临床队列中的缺铁与全因住院风险
Chronic Obstr Pulm Dis. 2025 Jan 29;12(1):72-81. doi: 10.15326/jcopdf.2024.0550.
4
Ferroptosis-Mediated Inflammation Promotes Pulmonary Hypertension.铁死亡介导的炎症促进肺动脉高压。
Circ Res. 2024 Nov 8;135(11):1067-1083. doi: 10.1161/CIRCRESAHA.123.324138. Epub 2024 Oct 18.
5
Intravenous iron supplementation in pulmonary hypertension groups 1 to 4.静脉铁补充治疗 1 至 4 组肺动脉高压。
Int J Med Sci. 2024 Aug 1;21(11):2011-2020. doi: 10.7150/ijms.92904. eCollection 2024.
6
Genetic information supports a causal relationship between trace elements, inflammatory proteins, and COPD: evidence from a Mendelian randomization analysis.遗传信息支持微量元素、炎症蛋白与慢性阻塞性肺疾病之间的因果关系：孟德尔随机化分析的证据
Front Nutr. 2024 Aug 14;11:1430606. doi: 10.3389/fnut.2024.1430606. eCollection 2024.
7
Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertension.未成熟网织红细胞比例：肺动脉高压血流动力学严重程度的一种新型生物标志物。
Pulm Circ. 2024 Aug 5;14(3):e12421. doi: 10.1002/pul2.12421. eCollection 2024 Jul.
8
Iron Deficiency in Heart Failure and Pulmonary Hypertension.心力衰竭和肺动脉高压中的缺铁
Curr Treat Options Cardiovasc Med. 2022 Dec;24(12):213-229. doi: 10.1007/s11936-022-00971-4. Epub 2022 Oct 4.
9
Ferroptosis Integrates Mitochondrial Derangements and Pathological Inflammation to Promote Pulmonary Hypertension.铁死亡整合线粒体紊乱与病理性炎症以促进肺动脉高压。
bioRxiv. 2024 Sep 23:2023.01.19.524721. doi: 10.1101/2023.01.19.524721.
10
Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension.Bmpr2突变小鼠并非用于研究肺动脉高压中铁缺乏的理想模型。
Pulm Circ. 2022 Oct 1;12(4):e12151. doi: 10.1002/pul2.12151. eCollection 2022 Oct.

本文引用的文献

1
Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials.肺动脉高压的铁补充。两项随机交叉试验。
Ann Am Thorac Soc. 2021 Jun;18(6):981-988. doi: 10.1513/AnnalsATS.202009-1131OC.
2
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压患者应用吸入曲前列尼尔治疗
N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13.
3
Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial.静脉铁剂与慢性阻塞性肺疾病：一项随机对照试验。
BMJ Open Respir Res. 2020 Jun;7(1). doi: 10.1136/bmjresp-2020-000577.
4
Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.慢性肺部疾病导致肺动脉高压患者的生存率：一氧化碳肺弥散量降低的影响。
J Heart Lung Transplant. 2019 Feb;38(2):145-155. doi: 10.1016/j.healun.2018.09.011. Epub 2018 Sep 14.
5
The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension.缺铁定义对毛细血管前性肺动脉高压病程的关键影响。
PLoS One. 2018 Aug 30;13(8):e0203396. doi: 10.1371/journal.pone.0203396. eCollection 2018.
6
Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada.世界卫生组织1至4组肺动脉高压的发病率和患病率不断上升：加拿大安大略省的一项基于人群的队列研究。
Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e003973. doi: 10.1161/CIRCOUTCOMES.117.003973.
7
Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency.特发性肺动脉高压合并缺铁患者的静脉铁剂治疗
Pulm Circ. 2015 Sep;5(3):466-72. doi: 10.1086/682217.
8
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease.一项关于慢性阻塞性肺疾病患者队列中铁缺乏症患病率及相关性的横断面研究。
BMJ Open. 2015 Jul 6;5(7):e007911. doi: 10.1136/bmjopen-2015-007911.
9
Iron deficiency in patients with idiopathic pulmonary arterial hypertension.特发性肺动脉高压患者的缺铁问题。
Heart Lung Circ. 2014 Mar;23(3):287-92. doi: 10.1016/j.hlc.2013.08.007. Epub 2013 Sep 1.
10
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target.肺动脉高压中的铁缺乏：一个潜在的治疗靶点。
Eur Respir J. 2011 Dec;38(6):1453-60. doi: 10.1183/09031936.00037711. Epub 2011 Apr 8.